Developer docs
API playgroundTry for free, no card

Search company profiles

PCM Trials

Full company profile

uuid00094yg

Namestring
PCM Trials
Legal namestring
Act for Health, Inc.
Websiteurl
pcmtrials.com
Company typeenum
Private
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDenver, United States
HQ citystring
Denver
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized clinical trials, mobile research services, community research sites, clinical trial patient recruitment, mobile research nursing
Industry3 codes
PRIMARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Decentralized Clinical Trial Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Mobile Research Services
TypeProfessional Services
Description

PCM Trials generates revenue by providing mobile clinical research services to pharmaceutical sponsors and CROs. CMRNs travel to trial participants to conduct study visits, collect samples, administer treatments, and gather data. Services are contracted per study with fees based on visit volume, procedures performed, and geographic coverage required. The company operates globally across 80+ countries following acquisitions of CTS and EmVenio.

pcmtrials.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based / Not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

The company uses a formal RFP process for pricing inquiries. No public pricing tiers or rate cards are available.

pcmtrials.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PCM Trials provides decentralized clinical trial services, primarily sending Certified Mobile Research Nurses (CMRNs) to participants' homes or community locations to conduct study visits, collect samples, administer treatments, and capture data via an eSource platform. The company also operates a global network of community-based clinical research sites, including mobile research units (MRUs) that can travel to underserved communities to deliver protocol procedures. Services are contracted per study by pharmaceutical sponsors and Contract Research Organizations (CROs).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50% lower dropout rates in trials with mobile visits vs. comparable trials without (GlobalData study)
+3 more records
Product overview1 text field

PCM Trials operates as a decentralized and hybrid clinical trial services provider, offering a unified platform of community-based research solutions. The core offering consists of Mobile Research Services driven by Certified Mobile Research Nurses (CMRNs), complemented by Community Research Sites (through EmVenio Research, acquired in 2024). The product ecosystem includes an eSource platform for electronic data capture and Patient Navigator™ for patient support. Following the 2024 acquisitions of Clinical Trial Service (CTS) and EmVenio Research, the company rebranded as EmVenio Clinical Research in August 2025, operating as the world's largest independent, community-based site network serving sponsors and CROs across over 80 countries.

Product and service5 records
1Mobile Research Services
CategoryDecentralized Clinical Trial Services
2Community Research Sites (EmVenio)
CategoryDecentralized Clinical Trial Services
3Certified Mobile Research Clinicians (CMRNs)
CategoryMobile Clinical Workforce
4eSource Platform
CategoryClinical Trial Data Capture
5Patient Navigator
CategoryPatient Support Services
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

Collaboration with Dr. Rohit Aggarwal and the University of Pittsburgh team on the MINT (Myositis Interstitial Lung Disease Nintedanib Trial) study. PCM Trials provides mobile nurse visit services for this decentralized trial. The study demonstrated successful integration of mobile visits enabling coast-to-coast patient enrollment including rural regions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-23
Description

Durham, North Carolina-based provider of community-based clinical trial sites acquired by PCM Trials in February 2024. EmVenio operates 63 mobile research sites across the US and UK, achieving over 50% diversity in patients. EmVenio is the largest provider of community-based clinical trial sites served by mobile research units, effectively reducing barriers to participation in underrepresented communities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-10
Description

Netherlands-based clinical research firm acquired by PCM Trials effective January 10, 2024. The acquisition expands PCM Trials' global reach to operate in over 80 countries and streamlines services. CTS is the longest-serving mobile research provider in Europe. CTS's team and operations in Europe continue under the same brand and staff to support ongoing and future trials.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DCT technology platform enabling decentralized and hybrid trials via eCOA, eConsent, telehealth, and remote patient monitoring. Comparable to PCM Trials as a DCT-focused vendor serving pharma sponsors and CROs.

TypeDirect peer
Description

DCT platform providing software-enabled decentralized and hybrid clinical trial execution, including home-based visits and telehealth. Comparable to PCM Trials in enabling community-based and remote trial delivery for sponsors.

TypeEmerging player
Description

Provides eCOA, eConsent, and other clinical trial technology solutions that enable decentralized and hybrid trials. Comparable to PCM Trials' eSource platform in supporting decentralized data capture, though more software-focused.

TypeBroad incumbent
Description

Large global CRO offering decentralized and hybrid trial solutions as part of its full-service clinical development offering. Competes with PCM Trials when sponsors seek integrated CRO+DCT bundles.

TypeBroad incumbent
Description

Major global CRO providing decentralized clinical trial services alongside traditional site management and clinical development. Overlaps with PCM Trials in mobile nursing, hybrid trial design, and biopharma sponsor relationships.

TypeDirect peer
Description

Direct competitor in decentralized clinical trial services, offering a DCT operating system and Metasite™ network for remote and hybrid trials. Highly comparable to PCM Trials in its mobile/in-home visit focus and sponsor customer base.

TypeOthers
Description

Cloud-based life sciences software platform with clinical trial management, eTMF, and patient engagement solutions that intersect with DCT technology stacks. Adjacent to PCM Trials as enabling infrastructure for decentralized trials.

TypeBroad incumbent
Description

World's largest CRO with extensive DCT and decentralized trial capabilities within a broad clinical development services portfolio. Competes with PCM Trials on enterprise sponsor RFPs that include decentralized and hybrid trial components.

TypeDirect peer
Description

Decentralized clinical trial platform offering remote data capture and virtual trial capabilities to sponsors and CROs. Direct DCT peer to PCM Trials in the hybrid/decentralized trial services space.

TypeBroad incumbent
Description

Diversified diagnostics and clinical development services provider offering decentralized trial capabilities alongside central lab services. Competes with PCM Trials on hybrid trial RFPs from pharma sponsors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PCM Trials

Decentralized Clinical Trial Servicespcmtrials.com

PCM Trials firmographics

Firmographics
Name
PCM Trials
Legal name
Act for Health, Inc.
Website
https://pcmtrials.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

PCM Trials industry classification

Industry
Product category
Decentralized Clinical Trial Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)

Keywords

  • Decentralized clinical trials
  • Mobile research services
  • Community research sites
  • Clinical trial patient recruitment
  • Mobile research nursing

Where PCM Trials is headquartered

Location

Headquarters

HQ city
Denver
HQ country
United States
HQ region
North America

Offices4 records

Markets served

PCM Trials business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Mobile Research Services: PCM Trials generates revenue by providing mobile clinical research services to pharmaceutical sponsors and CROs. CMRNs travel to trial participants to conduct study visits, collect samples, administer treatments, and gather data. Services are contracted per study with fees based on visit volume, procedures performed, and geographic coverage required. The company operates globally across 80+ countries following acquisitions of CTS and EmVenio.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based / Not publicly disclosed

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

PCM Trials product offering

Product offering

Core offering

PCM Trials provides decentralized clinical trial services, primarily sending Certified Mobile Research Nurses (CMRNs) to participants' homes or community locations to conduct study visits, collect samples, administer treatments, and capture data via an eSource platform. The company also operates a global network of community-based clinical research sites, including mobile research units (MRUs) that can travel to underserved communities to deliver protocol procedures. Services are contracted per study by pharmaceutical sponsors and Contract Research Organizations (CROs).

Product overview

PCM Trials operates as a decentralized and hybrid clinical trial services provider, offering a unified platform of community-based research solutions. The core offering consists of Mobile Research Services driven by Certified Mobile Research Nurses (CMRNs), complemented by Community Research Sites (through EmVenio Research, acquired in 2024). The product ecosystem includes an eSource platform for electronic data capture and Patient Navigator™ for patient support. Following the 2024 acquisitions of Clinical Trial Service (CTS) and EmVenio Research, the company rebranded as EmVenio Clinical Research in August 2025, operating as the world's largest independent, community-based site network serving sponsors and CROs across over 80 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mobile Research Services
  • Community Research Sites (EmVenio)
  • Certified Mobile Research Clinicians (CMRNs)
  • eSource Platform
  • Patient Navigator

Quantifiable outcome

  • 50% lower dropout rates in trials with mobile visits vs. comparable trials without (GlobalData study)
  • +3 more outcomes

Companies that use PCM Trials

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

PCM Trials technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

PCM Trials partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • University of PittsburghcoreStrategic or Co-development Partner · 1 August 2024Collaboration with Dr. Rohit Aggarwal and the University of Pittsburgh team on the MINT (Myositis Interstitial Lung Disease Nintedanib Trial) study. PCM Trials provides mobile nurse visit services for this decentralized trial. The study demonstrated successful integration of mobile visits enabling coast-to-coast patient enrollment including rural regions.
  • EmVenio ResearchcoreStrategic or Co-development Partner · 23 February 2024Durham, North Carolina-based provider of community-based clinical trial sites acquired by PCM Trials in February 2024. EmVenio operates 63 mobile research sites across the US and UK, achieving over 50% diversity in patients. EmVenio is the largest provider of community-based clinical trial sites served by mobile research units, effectively reducing barriers to participation in underrepresented communities.
  • Clinical Trial Service (CTS)coreStrategic or Co-development Partner · 10 January 2024Netherlands-based clinical research firm acquired by PCM Trials effective January 10, 2024. The acquisition expands PCM Trials' global reach to operate in over 80 countries and streamlines services. CTS is the longest-serving mobile research provider in Europe. CTS's team and operations in Europe continue under the same brand and staff to support ongoing and future trials.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

PCM Trials competitors and assessment

Company assessment

Direct peers

  • Medable: DCT technology platform enabling decentralized and hybrid trials via eCOA, eConsent, telehealth, and remote patient monitoring. Comparable to PCM Trials as a DCT-focused vendor serving pharma sponsors and CROs.
  • Curebase: DCT platform providing software-enabled decentralized and hybrid clinical trial execution, including home-based visits and telehealth. Comparable to PCM Trials in enabling community-based and remote trial delivery for sponsors.
  • Science 37: Direct competitor in decentralized clinical trial services, offering a DCT operating system and Metasite™ network for remote and hybrid trials. Highly comparable to PCM Trials in its mobile/in-home visit focus and sponsor customer base.
  • THREAD Research (now THREAD, a Curebase company): Decentralized clinical trial platform offering remote data capture and virtual trial capabilities to sponsors and CROs. Direct DCT peer to PCM Trials in the hybrid/decentralized trial services space.

Emerging players

  • Signant Health: Provides eCOA, eConsent, and other clinical trial technology solutions that enable decentralized and hybrid trials. Comparable to PCM Trials' eSource platform in supporting decentralized data capture, though more software-focused.

Broad incumbents

  • ICON plc: Large global CRO offering decentralized and hybrid trial solutions as part of its full-service clinical development offering. Competes with PCM Trials when sponsors seek integrated CRO+DCT bundles.
  • Parexel International: Major global CRO providing decentralized clinical trial services alongside traditional site management and clinical development. Overlaps with PCM Trials in mobile nursing, hybrid trial design, and biopharma sponsor relationships.
  • IQVIA: World's largest CRO with extensive DCT and decentralized trial capabilities within a broad clinical development services portfolio. Competes with PCM Trials on enterprise sponsor RFPs that include decentralized and hybrid trial components.
  • Labcorp (Clinical Development & Decentralized Trials): Diversified diagnostics and clinical development services provider offering decentralized trial capabilities alongside central lab services. Competes with PCM Trials on hybrid trial RFPs from pharma sponsors.

Others

  • Veeva Systems: Cloud-based life sciences software platform with clinical trial management, eTMF, and patient engagement solutions that intersect with DCT technology stacks. Adjacent to PCM Trials as enabling infrastructure for decentralized trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PCM Trials social profiles

Digital presence

PCM Trials compliance and trust

Trust signal

Compliance9 records

PCM Trials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PCM Trials leadership team

Management profile

Number of profiles

Profiles10 records

PCM Trials subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

PCM Trials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PCM Trials M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PCM Trials

What does PCM Trials do?

PCM Trials provides decentralized clinical trial services, primarily sending Certified Mobile Research Nurses (CMRNs) to participants' homes or community locations to conduct study visits, collect samples, administer treatments, and capture data via an eSource platform. The company also operates a global network of community-based clinical research sites, including mobile research units (MRUs) that can travel to underserved communities to deliver protocol procedures. Services are contracted per study by pharmaceutical sponsors and Contract Research Organizations (CROs).

Is PCM Trials a public or private company?

PCM Trials is a private company. It is classified as corporate owned and is currently operating.

When was PCM Trials founded?

PCM Trials was founded in 2008. It employs 101 to 250 people.

Where is PCM Trials based?

PCM Trials is headquartered in Denver, United States, in the North America region.

How does PCM Trials make money?

One revenue line is on record: mobile Research Services.

Who are PCM Trials's main competitors?

Direct peers on record are Medable, Curebase, Science 37 and THREAD Research (now THREAD, a Curebase company). Signant Health is listed as an emerging player. Broad incumbents are ICON plc, Parexel International, IQVIA and Labcorp (Clinical Development & Decentralized Trials). Veeva Systems is listed as an others.

Does PCM Trials have an API?

No public API is recorded for PCM Trials.

What industry is PCM Trials in?

PCM Trials's product category is Decentralized Clinical Trial Services. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comTop Players and Industry Competition in the Virtual Clinical Trials MarketThe virtual clinical trials market is projected to reach $21.58 billion by 2030, growing at a compound annual growth rate of 10.7%, driven by increasing demand for remote healthcare delivery and decentralized trial methodologies. In February 2024, PCM Trials, a US-based home healthcare provider, acquired EmVenio Research Inc. to strengthen its ability to recruit and retain diverse participant populations through access to EmVenio's site network focused on underserved communities. In August 2024, Medable Inc. launched Medable Studio, a no-code digital trial platform that enables sponsors to build and launch clinical workflows through a point-and-click interface, aimed at reducing trial timelines and costs.PR NewswirePCM Trials, EmVenio Research y Clinical Trial Service cambian su nombre a EmVenio Clinical ResearchPCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, announced they are consolidating under a single brand name: EmVenio Clinical Research. The rebranding unifies the three companies—which offer complementary clinical trial services including mobile nurse visits, decentralized trials, and community research sites—into one entity operating across more than 80 countries with approximately 5,000 professionals. As part of the announcement, the company also launched Patient Navigator™, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation, particularly in rare disease and pediatric therapeutic areas.PR NewswirePCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical ResearchPCM Trials, EmVenio Research, and Clinical Trial Service have consolidated under the unified brand EmVenio Clinical Research to offer sponsors and contract research organizations greater flexibility and global reach, now operating in over 80 countries with approximately 5,000 professionals. The rebranded entity is also launching Patient Navigator™, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation and improve patient retention. PCM Trials had previously acquired Clinical Trial Service in 2024 and subsequently acquired EmVenio Research, forming the alliance now unified under the EmVenio name.PR NewswirePCM Trials, EmVenio Research et Clinical Trial Service changent de nom pour devenir EmVenio Clinical ResearchPCM Trials and its subsidiaries EmVenio Research and Clinical Trial Service have consolidated under a single brand name, EmVenio Clinical Research, effective August 25, 2025, uniting their complementary service lines under one entity within Professional Case Management. The rebranded company also launched Patient Navigator, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation, particularly in rare diseases and pediatrics. EmVenio Clinical Research now operates in over 80 countries with approximately 5,000 professionals, claiming the ability to recruit more than 75% of patients from minority populations and retain over 92% of trial participants.PR NewswirePCM Trials, EmVenio Research und Clinical Trial Service firmieren um in EmVenio Clinical ResearchPCM Trials, EmVenio Research, and Clinical Trial Service have consolidated under a unified brand, EmVenio Clinical Research, uniting their complementary capabilities in decentralized clinical trials under a single operating name. The combined entity now operates in over 80 countries with approximately 5,000 professionals, leveraging mobile teams and community-based research sites to improve patient access and retention in clinical studies. EmVenio is also launching Patient Navigator, a personalized support service designed to reduce logistical and financial barriers to trial participation, particularly in rare diseases and pediatrics.PR NewswirePCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical ResearchEmVenio Clinical Research, a subsidiary of Professional Case Management, has consolidated three entities—PCM Trials, EmVenio Research, and Clinical Trial Service—under a unified brand to offer sponsors and contract research organizations greater flexibility and global reach. The company now operates in over 80 countries with approximately 5,000 professionals and has launched Patient Navigator™ to reduce logistical and financial barriers to clinical trial participation. PCM Trials, founded in 2008 and known for decentralized clinical trials, acquired Clinical Trial Service and EmVenio Research in 2024 to form this alliance.YahooFive common misconceptions about mobile visits in clinical trialsPCM Trials addresses five misconceptions about mobile visits in clinical trials, including nurse assignment, privacy, protocol complexity, and IV administration. The company reports supporting over 430 trials in more than 80 countries with over 70,000 visits. It also notes mobile visits can be used for complex protocols and IV infusions.PR NewswirePCM Trials and EmVenio Research Announce the Appointment of Jeff Huntsman as Chief Commercial OfficerPCM Trials and its subsidiary EmVenio Research have appointed Jeff Huntsman as Chief Commercial Officer to lead their global commercial organization. This leadership addition supports the companies' strategic growth in the clinical trial industry, particularly within hybrid and decentralized models. The move aims to leverage Huntsman's extensive experience in business development to enhance competitive positioning and market expansion.